Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
about
Is dietary fat, vitamin D, or folate associated with pancreatic cancer?Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.Vitamin D and GI cancers: shedding some light on dark diseasesInhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.Mechanistic Effects of Calcitriol in Cancer BiologyDual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistanceCalcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer.SULT2B1b sulfotransferase: induction by vitamin D receptor and reduced expression in prostate cancer.Effects of 1,25(OH)₂D₃ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents.Vitamin D in oncology.Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR.Vitamin D has wide regulatory effects on histone demethylase genes.Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer.Vitamin D in combination cancer treatment.Inverse association of vitamin D3 levels with lung cancer mediated by genetic variation.The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation
P2860
Q26851126-5AB42203-8F46-4739-B2DE-A49EB76BFB34Q34253198-572E57CC-B3A8-466A-B176-819F86690D94Q34357880-A1DBA44F-11BD-4CF3-AED8-8249E081F225Q34566030-8BA8BF20-C2E8-4BF7-86A1-5D33E31B65CEQ35537834-4C69A31C-70CE-4693-9D32-E5A3022CC69FQ35809076-21C87397-18EF-44E1-89A7-FE0B4532DA0EQ35954885-EB39FEF9-6994-44BB-88A4-68F7107FBD33Q36279579-D06FF513-B189-435D-AEB7-393F1B2A55C9Q36850145-575EF0CC-A2C2-4DE0-B5DF-FCAE8E1E470AQ37628495-0C3E461E-6DC7-41B4-953D-B740AB8A4F9DQ37936093-911373D2-24FA-4438-949F-48E0A42369F3Q38914179-6CB7AB39-BE60-4636-BAB3-306925D0385FQ39295094-6EB399B9-2DCA-4E19-A2ED-ABF0107CFEAFQ39389302-7A827472-0816-469E-9FA2-0F6105C4BA74Q39564543-ACDE91E0-1354-4F9D-96F4-6F3578B01E69Q39796064-EE6E16B4-AD91-4F85-A8DF-96535A6EE489Q41694103-35474507-F41D-4395-A4E9-2FDBFCAA93BCQ41999286-BD3C579E-C404-4C8F-B975-29A5EB3CA559Q42427858-8E17096F-784A-4B7A-8738-CEB00E08C12FQ55283827-50DCB4DC-565D-4675-9FC5-CFA5CC7F0836Q58783408-67CE6085-C6CC-4B60-9228-D4788C9DBC18
P2860
Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@en
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@nl
type
label
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@en
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@nl
prefLabel
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@en
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@nl
P2093
P2860
P356
P1433
P1476
Calcitriol enhances gemcitabin ...... reatic carcinoma model system.
@en
P2093
Candace S Johnson
Donald L Trump
Geraldine Flynn
Josephia R Muindi
Rui-Xian Kong
Wei-Dong Yu
P2860
P304
P356
10.4161/CC.9.15.12381
P577
2010-08-17T00:00:00Z